China Interventional Cardiovascular Device Industry Report, 2010
  • Jan/2011
  • Hard Copy
  • USD $1,800
  • Pages:73
  • Single User License
    (PDF Unprintable)       
  • USD $1,700
  • Code: ZT004
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,300
  • Hard Copy + Single User License
  • USD $2,000
      
In recent years, the prevalence rate of cardiovascular disease has increased year by year. According to the data issued by Ministry of Health of the People’s Republic of China, there were 20 million patients with coronary artery disease in China 2008, and the number rises at the annual growth of more than 1 million. The growth spurt of the patients suffering from heart disease has stimulated the fast growing demand for interventional cardiology operations and coronary stents.

In China, the number of PCI operation cases rose from 25,000 in 2002 to 242,000 in 2009; the coronary stent implantation amount increased from 40,000 sets in 2002 to 387,000 in 2009. In 2009, Chinese market size of interventional cardiovascular device (by terminal sales revenue of hospitals) reached RMB8.16 billion, up 30% from a year earlier.

PCI Operation Cases and Coronary Stent Implantation Amount in China, 2002-2012 (Unit: 1,000 cases)
 2011026001.gif
Source: China Association for Medical Devices Industry, ResearchInChina

Interventional cardiovascular device includes coronary stent and surgical support equipment. In 2009, Chinese coronary stent market valued RMB5.71 billion; and the market size of surgical support equipment (including balloon catheter, catheter, and guide wire) hit RMB2.46 billion. The ratio of the two markets was about 7:3.

Before 2004, foreign companies dominated Chinese coronary stent market. Because of incessantly exploring core technologies and accumulating experience, Chinese enterprises enjoy the rising market shares yearly and even more than foreign counterparts by virtue of advantages in price and channel. By the amount of implantation, domestic enterprises swept about 77.7% market shares in 2009, while foreign peers took approximately 22.3%; by the terminal sales revenue of hospitals, domestic enterprises held around 66.8% market shares in 2009, while foreign ones occupied 33.2% or so.

Coronary Stent Market Shares in China (by Sale of Hospitals), 2009
 2011026002.gif
Source: MicroPort, ResearchInChina

In 2009, MicroPort Scientific, Lepu Medical and JW Medical ranked the top three in terms of the market share of coronary stent; by the terminal sales revenue of hospitals, MicroPort Scientific, Lepu Medical and JW Medical took the market share of 25.1%, 20.5% and 18.5% respectively. Remarkably, MicroPort and Lepu are with the diversified product lines of interventional cardiovascular device, and both of them focus on coronary stent and also pay attention to angiography catheter, guidewire, sheath introducer kit, etc, with the objective of ultimately covering the entire field of interventional cardiovascular devices. In addition, MicroPort and Lepu are making more efforts in the R&D of interventional cardiovascular devices. MicroPort is now developing the third-generation drug-eluting stent “Firehawk” , while Lepu is developing a new generation of magnesium alloy biodegradable stents.

However, in surgical supporting device market consisting of balloon catheter, catheter and guidewire, due to technical limitations, only less than 20% of products are made in China. The market is dominated by Cordis, J & J, Medtronic, Boston and other foreign brands. Yet, Chinese enterprises may simulate the development modes of those foreign companies. MicroPort, Lepu, Fisuntech, TemMed and other companies are enhancing R&D and production of surgical supporting instruments. In the future, the competition in the market of interventional cardiovascular supporting devices will intensify.

The report is based on social, economic and policy environments, the overall operation, market competition and development trends of Chinese interventional cardiovascular device industry. It not only studies such market segments as coronary stents, balloon catheters, catheters, guidewires, assistive devices and others in China, but also analyzes the operation and development of 12 major interventional cardiovascular device manufacturers including J & J Cordis, Medtronic, Boston Scientific, Abbott Guidant, B. Braun, MicroPort, Lepu, JW, Yinyi, OrbusNeich, Fisuntech, SCW Medical.
1 Overview of Interventional Cardiovascular Device Industry 
1.1 Definition
1.2 Product Category and Application
1.3 Industry Chain

2 Development of Interventional Cardiovascular Device Industry in China
2.1 International Environment
2.2 Industry Overview
2.3 Supply and Demand
2.4 Market Scale and Gross Profit
2.5 Competition Pattern
2.6 Related Policies
2.6.1 Laws and Regulations
2.6.2 Development Policies
2.6.3 Sales Policies
2.7 Import
2.8 Development Trends
2.8.1 Health Care Reform Improves People’s Spending Power
2.8.2 Diversification of Product Lines

3 Interventional Cardiovascular Market Segments
3.1 Coronary Stent
3.1.1 Market Overview
3.1.2 Drug-eluting Stent   
3.1.3 Bare Metal Stent 
3.1.4 Bioabsorbable Stent 
3.2 Balloon Catheter
3.2.1 Market Overview
3.2.2 Supply & Demand
3.3 Catheter
3.3.1 Market Overview
3.3.2 Sale
3.4 Guidewire 
3.4.1 Market Overview
3.4.2 Sale
3.5 Sheath Introducer Kit and Auxiliary Device
3.5.1 Market Overview
3.5.2 Sale

4 Foreign Production Enterprises
4.1 Cordis, J&J
4.1.1 Profile
4.1.2 Operation
4.1.3 Operation in China
4.2 Medtronic
4.2.1 Profile
4.2.2 Operation
4.2.3 Operation in China
4.3 Boston Scientific
4.3.1 Profile
4.3.2 Operation
4.3.3 Operation in China
4.4 Guidant , Abbott
4.4.1 Profile
4.4.2 Operation
4.4.3 Operation in China
4.5 B.Braun
4.5.1 Profile
4.5.2 Operation
4.5.3 Operation in China

5 Chinese Production Enterprises
5.1 MicroPort Scientific
5.1.1Profile
5.1.2 Operation
5.1.3 Development
5.2 Lepu Medical
5.2.1 Profile
5.2.2 Operation
5.1.3 Development
5.3 JW Medical
5.3.1 Profile
5.3.2 Operation
5.3.3 Development
5.4 Yinyi
5.4.1 Profile
5.4.2 Operation
5.4.3 Features
5.5 OrbusNeich
5.5.1 Profile
5.5.2 Operation
5.5.3 Features
5.6 Fuji Suntech
5.6.1 Profile
5.6.2 Operation
5.6.3 Development
5.7 SCW Medical
5.7.1 Profile
5.7.2 Operation
5.7.3 Development
Types and Functions of Interventional Cardiovascular Devices
Types and Characteristics of Cardiovascular Stents
China Interventional Cardiovascular Device Industry Chain
Global Market Scale of Interventional Cardiology Devices, 2005-2012 
Coronary Stent Sales Volume of Major Brands in the World, 2009
Scale and Growth Rate of Chinese Medical Device Market, 2002-2009
Total Number and Growth Rate of Hospitals in China, 2005-2010
Main Interventional Cardiovascular Device Companies in China
Number of People Aged 65 or above and Proportion in Some Countries, 2010
Prevalence of Heart Disease and Hypertension in China, 1993-2008
Number of PCI Operation Cases in China, 2002-2012
Coronary Stent Implantation Number in China, 2002-2012
Interventional Cardiovascular Device Market Size in China, 2009
Gross Margins of Major Interventional Cardiovascular Device Manufacturers in China, 2007-2009
Coronary Stent Market Shares in China (by Implantation Volume and Sales of Hospitals), 2009
Major Laws and Regulations concerning Medical Device Industry in China
Policies Related to Interventional Cardiovascular Device Industry
Sales Channels of Interventional Cardiovascular Devices in China
Average Price Comparison bettwen Coronary Stents Procured by Ministry of Health of the P.R.C and the Imported Ones, 2008-2010
Import of Major Interventional Medical Devices and Materials in China, 2008
Charges of Interventional Operations paid by Health Insurance in Beijing, Shanghai and Guangzhou, 2010
Urban Health Insurance Participants and Growth Rate in China, 2000-2009
Equipment Product Line Layout of MicroPort, Lepu and JW Medical
Coronary Stent Market Scale in China, 2007-2015
Coronary Stent Market Shares in China (by Volume of Implanted Stents), 2009
Coronary Stent Market Shares in China (by Sale of Hospitals), 2009
Drug-eluting Stents in China, 2010
Some Bare Metal Stents in China, 2010
Demand for Coronary Artery Balloon Catheters in China, 2002-2009
Average Purchase Price of Balloon Catheters in China, 2010
Some Rapid Exchange Expansion Balloon Catheters in China, 2010
Average Purchase Price of Catheters in China, 2010
Guide Catheters in China, 2010
Average Purchase Price of Guidewires in China, 2010
Some Guidewires in China, 2010
Average Purchase Price of Sheath Introducer Kit and Auxiliary Equipment in China, 2010
Medical Device Revenue, Cordis Revenue and Proportion of Johnson & Johnson, 2007-2010
Cardiovascular Product Revenue, Coronary Stent Revenue and Proportion of Medtronic, FY2007-FY2011
Main Operating Indicators of Medtronic (Shanghai), 2007-2008
Total Revenue, Coronary Stent Revenue and Proportion of Boston Scientific, 2008-2010
Revenue and Growth Rate of of Abbott's Vascular Device Sector, 2008-2010
Revenue and Growth Rate of of B. Braun Aesculap, 2006-2009
Main Operating Indicators of B.Braun (Suzhou), 2008 
Operating Income, Gross Margin and Revenue Growth Rate of MicroPort Scientific, 2007-2010         
Revenue (by Product) of MicroPort Scientific, 2007-2010
Revenue (by Region) of MicroPort Scientific, 2007-2010    
R&D Expenditure and Its proportion in Sales Revenue of MicroPort Scientific, 2007-2010
R &D of New Products of MicroPort Scientific, by Sep 2010
Capacity, Actual Output and Utilization of Stents and Catheters of MicroPort Scientific, 2007-2010
Operating Income, Gross Margin and Revenue Growth Rate of Lepu Medical, 2007-2010   
Sales Gross Margin (by Product) of Lepu Medical, 2007-2010
Revenue (by Product) of Lepu Medical, 2008-2010       
Revenue (by Region) of Lepu Medical, 2010
R &D Expenditure and Its proportion in Sales Revenue of Lepu Medical, 2007-2009
R&D Layout of Lepu Medical 
Operating Income and Gross Margin of JW Medical, 2007-2008
Main Operating Indicators of Liaoning Biomedical Materials, 2008
Operating Income, Gross Margin and Revenue Growth Rate of OrbusNeich, 2005-2008
Export Value of OrbusNeich, 2005-2008
Main Operating Indicators of Fuji Suntech, 2008
Operating Income, Gross Margin and Revenue Growth Rate of SCW Medical, 2005-2008         
Export Value of SCW Medical, 2005-2008

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统